Pharmacotherapy of post-traumatic stress disorder: Going beyond the guidelines

dc.contributor.author

Davidson, J

dc.date.accessioned

2022-10-01T18:00:41Z

dc.date.available

2022-10-01T18:00:41Z

dc.date.issued

2016-01-01

dc.date.updated

2022-10-01T18:00:40Z

dc.description.abstract

This article discusses the study of Harpaz-Rotem and associates, who examined patterns of medication use in first-diagnosed veterans with post-traumatic stress disorder (PTSD). It considers the difference between practice guidelines and actual prescribing; selectively identifies issues with antidepressants, antipsychotics, benzodiazepines and prazosin; and reviews the possible impact of new medications in the pipeline.

dc.identifier.issn

2056-4724

dc.identifier.uri

https://hdl.handle.net/10161/25993

dc.language

en

dc.publisher

Royal College of Psychiatrists

dc.relation.ispartof

BJPsych Open

dc.relation.isversionof

10.1192/bjpo.bp.116.003707

dc.title

Pharmacotherapy of post-traumatic stress disorder: Going beyond the guidelines

dc.type

Journal article

pubs.begin-page

E16

pubs.end-page

E18

pubs.issue

6

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Psychiatry & Behavioral Sciences

pubs.organisational-group

Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology

pubs.publication-status

Published

pubs.volume

2

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Br J Psych Open - PTSD drug guidelines - 2016.pdf
Size:
216.4 KB
Format:
Adobe Portable Document Format